Ben Brockway Selected Research

Ben Brockway Research Topics

5	Infections 01/2023 - 11/2014
3	Cystic Fibrosis (Mucoviscidosis) 01/2023 - 11/2018
2	Hemorrhage 01/2019 - 11/2014
1	Lung Neoplasms (Lung Cancer) 04/2024
1	Starvation 01/2023
1	Stroke (Strokes) 01/2021
1	Vocal Cord Dysfunction 01/2019
1	Empyema 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016
1	Inflammation (Inflammations) 01/2016
1	Pain (Aches) 11/2014

3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 11/2018
2	Deoxyribonucleases (DNase)FDA Link 01/2021 - 11/2014
1	Cell-Free Nucleic AcidsIBA 04/2024
1	Oxygen (Dioxygen)IBA 01/2023
1	Ciprofloxacin (Cipro)FDA LinkGeneric 11/2019
1	Ceftazidime (Fortum)FDA LinkGeneric 11/2019
1	Tobramycin (Nebcin)FDA LinkGeneric 11/2019
1	Meropenem (Merrem)FDA LinkGeneric 11/2019
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2019
1	fibrinolytic agent LTI-01IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 11/2018
1	SteroidsIBA 01/2016
1	Bronchodilator Agents (Bronchodilators)IBA 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2014

4	Therapeutics 04/2024 - 11/2014
1	Length of Stay 01/2021
1	Nebulizers and Vaporizers (Inhaler) 01/2019
1	Thrombolytic Therapy 01/2019
1	Polypharmacy 01/2019
1	Continuous Positive Airway Pressure 12/2017
1	Aftercare (After-Treatment) 01/2016
1	Analgesia 11/2014